Andere Kunden interessierten sich auch für
![Détermination de l'ADN libre de cellules (cfDNA) par RT-qPCR - une perspective dans PMA]( "Détermination de l'ADN libre de cellules (cfDNA) par RT-qPCR - une perspective dans PMA")
Détermination de l'ADN libre de cellules (cfDNA) par RT-qPCR - une perspective dans PMA26,99 €![Bestimmung zellfreier DNA (cfDNA) mittels RT-qPCR - eine Perspektive in PMA]( "Bestimmung zellfreier DNA (cfDNA) mittels RT-qPCR - eine Perspektive in PMA")
Bestimmung zellfreier DNA (cfDNA) mittels RT-qPCR - eine Perspektive in PMA39,90 €![Determinazione del DNA privo di cellule (cfDNA) mediante RT-qPCR - una prospettiva in PMA]( "Determinazione del DNA privo di cellule (cfDNA) mediante RT-qPCR - una prospettiva in PMA")
Determinazione del DNA privo di cellule (cfDNA) mediante RT-qPCR - una prospettiva in PMA26,99 €![Determinação do DNA livre de células (cfDNA) por RT-qPCR - uma perspectiva em PMA]( "Determinação do DNA livre de células (cfDNA) por RT-qPCR - uma perspectiva em PMA")
Determinação do DNA livre de células (cfDNA) por RT-qPCR - uma perspectiva em PMA26,99 €![Opredelenie beskletochnoj DNK (cfDNA) metodom RT-qPCR - perspektiwy w PMA]( "Opredelenie beskletochnoj DNK (cfDNA) metodom RT-qPCR - perspektiwy w PMA")
Opredelenie beskletochnoj DNK (cfDNA) metodom RT-qPCR - perspektiwy w PMA13,99 €![Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics]( "Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics")
Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics81,99 €![Effect of Tamoxifen Citrate on Sperm Parameters And DNA fragmentation]( "Effect of Tamoxifen Citrate on Sperm Parameters And DNA fragmentation")
Effect of Tamoxifen Citrate on Sperm Parameters And DNA fragmentation26,99 €
The use of circulating nucleic acids as diagnostic and/or prognostic tools in oncology has been widely documented. Likewise, in gynecology and obstetrics, the development of a non-invasive prenatal diagnostic tool, based on the study of these biomarkers, has confirmed their growing interest in this discipline. Apart from the oncological interest of these free DNA fragments, Assisted Reproduction has discovered an easily measurable molecular tool guiding the management of infertile couples. Several studies have focused on the microRNAs present in the ovarian follicle and their involvement in folliculogenesis. Regarding the assay of cell-free DNA in seminal plasma of men with sperm alterations, there are no solid data yet. The level of cell-free DNA varies depending on the pathophysiological context and reflects the proportion of apoptotic and/or necrotic events occurring in the body. Therefore, its blood test could provide additional help to practitioners in the assessment of ovarian functional status. The cell-free nucleic acids could constitute new biomarkers predictive of oocyte and/or embryonic quality and represent a promising avenue in the prevention of implantation failures.